▲ BUY
10
/ 10
Conviction
$ Value
$320K
Shares
20,000
Price
$16
Filed
Feb 11
▶ Why this score? (10/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ % of holdings >= 50% (+3)
- ✓ Director (+1)
- ✓ Cluster: 15 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Khan Bilal Arshad
Title
—
CIK
0002108044
Roles
Director
Transaction Details
Transaction Date
2026-02-09
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
25,450
Footnotes
Shares held by New World Medical, Inc. (New World Medical). The Reporting Person is the Chief Executive Officer of New World Medical and as such has voting and investment control over the shares held by New World Medical. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of their pecuniary interest in the shares.
Filing Info
Khan Bilal Arshad's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-09 | SGP | ▲ | $320K |
| 2026-02-09 | SGP | ▲ | $1.8M ★ |
| 2026-02-05 | SGP | A | $0 |
Other Insiders at SGP (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $59.0M | — | 2026-02-09 |
| SANDELL SCOTT D | $15.0M | — | 2026-02-09 |
| BASKETT FOREST | $15.0M | — | 2026-02-09 |
| Mathers Edward T | $15.0M | — | 2026-02-09 |
| Walker Paul Edward | $15.0M | — | 2026-02-09 |
| Florence Anthony A. Jr. | $15.0M | — | 2026-02-09 |
| Behbahani Ali | $15.0M | — | 2026-02-09 |
| Makhzoumi Mohamad | $15.0M | — | 2026-02-09 |
| Chang Carmen | $15.0M | — | 2026-02-09 |
| New Enterprise Associates 17, L.P. | $15.0M | — | 2026-02-09 |
| Yang Rick | $15.0M | — | 2026-02-09 |
| Pardo Geoffrey B | $5.0M | — | 2026-02-09 |
| Nielsen Kirk G. | $2.6M | — | 2026-02-09 |
| Vensana Capital I GP, LLC | $2.6M | — | 2026-02-09 |
| Khan Bilal Arshad | $1.8M | — | 2026-02-09 |
|
Viret Jean-Frederic
Chief Financial Officer
|
— | — | 2026-02-05 |
| Dybbs Michael | — | — | 2026-02-05 |
| Dable Habib J | — | — | 2026-02-05 |
| O'Farrell Elizabeth G. | — | — | 2026-02-05 |
| Scheiner Zachary | — | — | 2026-02-05 |
|
Kahook Malik Y.
See remarks
|
— | — | 2026-02-05 |
|
Mooney Patrick H.
Chief Executive Officer
|
— | — | 2026-02-05 |
|
Dennewill James Robert Jr.
Chief Operating Officer
|
— | — | 2026-02-05 |
|
Pujara Chetan Pratap
Chief R&D Officer
|
— | — | 2026-02-05 |